AMS Health Sciences, Inc. Announces Third Quarter 2005 Financial Results

AMS Health Sciences, Inc., (Amex:AMM), today announced a
net loss for the third quarter 2005 of $513,868, or $(0.07) per common
(diluted) share, on 7.5 million shares outstanding, compared to a net
loss of $1,021,657, or $(0.15) per common (diluted) share, on 6.9
million shares outstanding in the third quarter of 2004. Sales totaled
$2.9 million for the quarter compared to sales of $4.5 million for the
quarter ended September 30, 2004.
   Cash, Marketable Securities and Trade Receivables at September 30,
2005 totaled $1.7 million compared to $3.6 million at December 31,
2004. The quick ratio of assets to liabilities was approximately 2:1,
compared to 3:1 at December 31, 2004, while shareholders' equity at
September 30, 2005 was $3.4 million compared to shareholders' equity
of $6.8 million at December 31, 2004.
   Sales for the first nine months of 2005 totaled $10.4 million
compared to $13.3 million for the same period in 2004. Net loss for
the first nine months of 2005 was $2,621,737, or ($0.36) per common
(diluted) share, on 7.2 million shares outstanding, compared to a net
loss of $1,909,963, or ($0.28) per common (diluted) share, on 6.7
million shares outstanding, in the year 2004.
   AMS Health Sciences, Inc., sells more than 60 natural nutritional
supplements, weight management products, and natural skincare products
through independent distributors across the U.S. and Canada. More
information about the Company is available at http://www.amsonline.com